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Abstract
 
Insulin-deficient diabetic rats are markedly hyperphagic
when fed a high-carbohydrate (HC) diet, but normophagic
when fed a high-fat (HF) diet. When maintained on a HC
diet, diabetic rats also exhibit increased gene expression of
the orexigenic peptide neuropeptide Y (NPY) in the hypo-
thalamic arcuate nucleus, and reduced expression of the an-
orectic peptide corticotropin-releasing hormone (CRH) in
the paraventricular nucleus, and these changes are hypothe-
sized to contribute to diabetic hyperphagia. In this experi-
ment we assessed whether the normophagia displayed by
HF-fed diabetic rats is associated with the opposite profile
of NPY and CRH expression. Our results show that relative
to diabetic rats on the HC diet, the diabetic rats on the HF
 
diet exhibited significantly reduced caloric intake (
 
2
 
40%),
NPY expression in the arcuate nucleus (
 
2
 
27%), and ele-
vated CRH expression in the paraventricular nucleus
(
 
1
 
37%). Insulin and corticosterone, which are known to af-
fect hypothalamic NPY and CRH expression, were not dif-
ferent between these two groups, making it unlikely that
they can account for the differences in either feeding behav-
ior or hypothalamic peptide expression. There was a small
but significant increase in plasma leptin levels in the dia-
betic animals maintained on the HF, and large differences
in parameters associated with elevated fat oxidation. These
observations support the hypothesis that the normalization
of food intake observed in diabetic rats consuming a HF diet
may in part be mediated by reductions in NPY expression
 
and elevations in CRH expression. (
 
J. Clin. Invest.
 
 1998.
 
102:340–346.) Key words: neuropeptide Y 
 
•
 
 corticotropin-
releasing hormone 
 
•
 
 high-fat diet 
 
•
 
 streptozotocin
 
Introduction
 
The hyperphagia of rats with uncontrolled insulin-dependent
diabetes mellitus has been extensively studied for many years
and has generated a number of hypotheses about the meta-
bolic controls of food intake (1). Many of the metabolic dis-
turbances associated with experimental diabetes have been
suggested as the cause of diabetic hyperphagia, including im-
paired glucose utilization (2), reduced body adiposity (3), and
low insulin concentrations (4–8). Other studies focusing on the
role of diet in diabetic hyperphagia suggest that overeating is
due to a lack of readily oxidizable fuels (9). Support for this
latter hypothesis is based in part on the observation that food
 
intake is normalized by feeding diabetic rats a high-fat (HF)
 
1
 
diet. More specifically, this hypothesis states that in the ab-
sence of insulin, fats are more readily oxidized than carbohy-
drates, and on the basis of their differential ability to extract
energy from the two nutrient sources, diabetic rats alter food
intake accordingly (10, 11). How the brain senses alterations in
fuel oxidation and what central nervous system (CNS) mecha-
nisms are involved in the changes in food intake in diabetic
rats fed a diet high in fat are unknown.
Hypothalamic neuropeptide Y (NPY) and corticotropin-
releasing hormone (CRH) are hypothesized to be involved in
diabetic hyperphagia (7). After the chemical induction of dia-
betes, NPY mRNA levels in the hypothalamic arcuate nucleus
(ARC) increase (5, 7), as does NPY content and release in the
paraventricular nucleus (PVN) (4, 6, 12). Support for the argu-
ment that elevated hypothalamic NPYergic activity contrib-
utes to diabetic hyperphagia is based in part on the observa-
tions that in nondiabetic animals, NPY injection into the PVN
stimulates food intake (13), and when repeatedly administered
into this region produces both persistent hyperphagia and obe-
sity (14). In diabetic rats on a high-carbohydrate (HC) diet,
CRH expression in the PVN is reduced (7). This observation is
consistent with diabetic hyperphagia in that acute CRH ad-
ministration into the PVN reduces food intake (15), and
chronic administration reduces both food intake and body
weight (16, 17). Moreover, there is evidence that CRH acts in
the PVN to directly oppose the stimulatory actions of hypotha-
lamic NPY on feeding (18).
One hypothesis that explains the changes in both hypotha-
lamic peptide systems and feeding behavior of diabetic rats fed
a HC diet is based on changes in the levels of insulin and corti-
costerone in the CNS. Elevated insulin concentrations within
the CNS are thought to reduce the production and release of
NPY in the hypothalamus, as well as food intake (19). Con-
versely, in the diabetic state, reduced CNS insulin concentra-
tions are proposed to result in the elevation of hypothalamic
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NPY activity, which in turn produces hyperphagia (7). In con-
trast to reduced insulin levels, plasma corticosterone concen-
trations are elevated in diabetic relative to nondiabetic rats
(20, 21), and this occurs despite the reduction in PVN CRH ex-
pression (7). Moreover, corticosterone administration to dia-
betic rats increases both ARC NPY expression and food in-
take in a dose-dependent manner (22).
To examine further the involvement of hypothalamic NPY
and CRH in the feeding behavior of diabetic rats, we manipu-
lated their food intake by feeding them diets either low or high
in fat. In nondiabetic rats, HF diets can increase caloric intake,
an effect opposite to that observed in diabetic animals. How-
ever, this effect is dependent on both the composition of the
diet and the strain of rat. To eliminate a potentially confound-
ing effect of the HF diet in the nondiabetic group, the compo-
sition of the diet (23) and strain of rat were selected specifi-
cally to have no effect on caloric intake in the nondiabetic
animals. This permitted a more specific assessment of the im-
pact of HF feeding on the hypothalamic responses to uncon-
trolled diabetes. This experimental manipulation provides a
powerful model since many of the metabolic disturbances of
diabetes persist in diabetic rats fed a HF diet despite the nor-
malization of food intake (9, 11).
Using this model we sought to determine whether this HF
feeding–induced normophagia in diabetic rats is associated
with reduced NPY mRNA levels in the ARC, and/or increased
CRH mRNA levels in the PVN, relative to diabetic rats on the
more standard HC diet. If this profile of hypothalamic peptide
expression is observed, it would suggest that the normophagia
exhibited by diabetic rats on a HF diet may be mediated, at
least in part, by opposing changes in NPY and CRH biosynthe-
sis. In addition, it would assess whether changes in these hypo-
thalamic systems can occur independently of differences in in-
sulin and/or corticosterone, and would permit us to investigate
other metabolic factors that may be driving peptide expression
in the hypothalamus. Alternatively, if diet does not affect the
hypothalamic expression of these two peptides, then it would
indicate that these hypothalamic systems are not involved in
the normophagia displayed by diabetic rats on the HF diet,
and would further suggest that the combination of elevated hy-
pothalamic NPY and reduced CRH biosynthesis does not nec-
essarily produce hyperphagia. Therefore, we measured food
intake, neuropeptide mRNA levels, circulating fuels, and
plasma insulin, corticosterone, and leptin levels, and compared
these to values measured in nondiabetic rats maintained on
one of the two different diets.
 
Methods
 
Male Long-Evans rats weighing an average of 346
 
6
 
7.3 g were ob-
tained from the breeding colony maintained by the Department of
Psychology at the University of Washington. Rats were housed indi-
vidually in a temperature-controlled environment (22
 
8
 
C) with a 12-h
light/12-h dark cycle. All rats had ad libitum access to pelleted rat
chow and tap water except where noted otherwise. The study proto-
col used in this experiment was approved by the Animal Care Com-
mittee at the University of Washington.
 
Experimental diabetes.
 
Animals were separated into two groups
of equivalent mean body weight and food intakes before streptozoto-
cin (STZ) or vehicle treatment. Rats in one group (
 
n
 
 5 
 
30) were
made diabetic while under light halothane anesthesia by tail vein in-
jection of STZ (65 mg/kg) (Sigma Chemical Co., St. Louis, MO) di-
luted in 0.5 ml sterile citrate buffer. Rats in the second group (
 
n
 
 5 
 
16
in total) were injected with citrate buffer only and served as nondia-
betic controls.
 
Experimental protocol.
 
After the STZ or vehicle treatments, the
two groups of animals were maintained on their standard chow diet
for 12 d with food intake and body weights monitored daily. At the
end of this interval one group each of the surviving diabetic rats (
 
n
 
 
 
5
 
14) and one group of nondiabetic rats (
 
n
 
 
 
5 
 
8) were placed on a HF
diet, and the remaining two groups were placed on the HC diet (
 
n
 
 
 
5
 
13 diabetic,
 
 n 
 
5 
 
7 nondiabetic). For diet composition see Table I.
Food intake and body weights were again monitored daily for the
next 12 d, after which animals were killed by decapitation. Trunk
blood was collected and brains were rapidly removed and frozen us-
ing liquid freon. Blood was kept on ice until the plasma was separated
and then stored at 
 
2
 
75
 
8
 
C until assayed for insulin, glucose, cortico-
sterone, leptin, triglycerides, free fatty acids, and ketone bodies.
 
Plasma assays.
 
Plasma insulin was measured by RIA using a kit
with a human insulin standard (Diagnostic Systems Lab, Webster,
TX) with a slight modification (7). Corticosterone was measured us-
ing a previously described RIA (24). Plasma glucose was determined
by the glucose oxidase method with a Beckman glucose autoanalyzer
(Beckman Instruments, Inc., Brea, CA). FFA were measured enzy-
matically using a commercially available kit (Wako Chemicals, Rich-
mond, VA). Triglycerides were assayed according to a modification
of the enzymatic method described by Wieland (25). Ketone bodies
(acetoacetate and 
 
b
 
-hydroxybutyrate) were measured using a modifi-
cation of the enzymatic procedure described by Bates et al. (26).
Leptin levels were measured by RIA for mouse leptin using a com-
mercially available kit (Linco, St. Louis, MO) (27). This mouse assay
is quite comparable to the results that are obtained from the now
available rat assays. The two assays are highly correlated (
 
r
 
 
 
5 
 
0.94)
and consequently while the absolute leptin levels reported by the two
assays may differ slightly, it is clear that the mouse assay provides ac-
curate information about the relative differences in leptin levels be-
tween the groups in this experiment (28).
 
In situ hybridization.
 
Coronal sections of frozen rat brain were
sectioned at 14 
 
m
 
m on a cryostat and mounted on RNase-free slides
stored at 
 
2
 
70
 
8
 
C. After tissue fixation, hybridization was performed
using antisense oligonucleotide probes based on cDNA sequences of
rat NPY or CRH genes (see reference 7 for details). The probes were
 
labeled with [
 
33
 
P]adenosine, and after hybridization slides they were
rinsed under high-stringency conditions and opposed to x-ray film to
generate autoradiographs, which were analyzed using computer den-
sitometry. Using a standard curve, autoradiograph optical density
and total hybridization area were determined using the MCID image
analysis system (Imaging Research, St. Catherines, Ontario, Canada).
 
Table I. Composition of Experimental Diets
 
Ingredients (g/100 g) HF/LC (HF) HC/LF (HC)
 
Casein 20.0 20.0
Cornstarch 10.4 52.0
Corn oil 23.1 4.6
Alphacel 41.5 18.4
AIN mineral mix 3.5 3.5
AIN vitamin mix 1.0 1.0
 
DL
 
-Methionine 0.3 0.3
Choline bitartrate 0.2 0.2
% kcal protein 24.0 24.0
% kcal fat 63.0 13.9
% kcal carbohydrate 13.0 63
kcal/g 3.3 3.3
 
AIN mixes are AIN 76 formulas (now AIN 93G).
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Measurements of NPY mRNA were made on six to eight sections per
rat from the midregion of the rostral-caudal extent of the ARC se-
lected by an investigator blind to the study conditions. Measurements
for CRH used a similar approach on sections obtained from the PVN.
Because of the number of animals and tissue sections involved in this
study, the diabetic and nondiabetic groups were run in separate as-
says. All densitometry data were collected by a technician blind to the
treatment group of the sections being analyzed. The product of hy-
bridization area and density was used as an index of overall mRNA
levels.
 
Statistics.
 
Food intake and body weight data used for graphical
presentation and statistical analysis are based on the last 3 d of each
of the three experimental time periods (pre-STZ baseline, post-STZ
period during which all animals were maintained on laboratory chow,
and days 9–12 after the animals had been consuming either the HF or
HC diets). Food intake and body weight data were analyzed by
ANOVA with three factors, diet, diabetes, and time, with time
treated as a repeated measure. Comparisons among individual means
were made by Tukey’s 
 
t
 
 test. Data derived from the plasma assays
were analyzed using an ANOVA with two factors, diet and diabetes,
followed by Bonferroni’s 
 
t
 
 test. Because the in situ hybridization as-
says were done at separate times for the diabetic and nondiabetic ani-
mals, statistical comparisons of mRNA levels between these groups
(diabetic vs. nondiabetic) cannot be made. Therefore, nonpaired,
two-tailed 
 
t
 
 tests were used to analyze the effect of the diet on mRNA
levels. In the text, table, and figures, all data are presented as
means
 
6
 
SEM.
 
Results
 
Food intake for the three experimental time periods is de-
picted in Fig. 1. Baseline food intake was not significantly dif-
ferent among the four groups of animals before STZ adminis-
 
tration (F{3,76} 
 
5 
 
0.18,
 
 P 
 
5 
 
0.91). After STZ administration
and during the period when all rats were maintained on stan-
dard laboratory chow, diabetic rats had significantly increased
food intake relative to nondiabetic controls (187.5
 
6
 
6.5 vs.
113
 
6
 
8 kcal) (F{1,76} 
 
5 
 
116.2,
 
 P 
 
, 
 
0.01). After the change from
the chow diet to the experimental diets, the diabetic animals
fed the HC diet continued to consume significantly more food
than the other three groups (F{3,76} 
 
5 
 
52.4,
 
 P 
 
, 
 
0.01 for inter-
action). In contrast, total daily caloric intake of the diabetic an-
imals on the HF diet did not differ significantly from either the
HF- or HC-fed nondiabetic control groups, and consumption
of the HF diet did not affect caloric intake in nondiabetic rats.
These results are consistent with other reports using a similar
protocol (9, 29, 30).
Body weights for the three experimental time periods are
depicted in Fig. 2. Before STZ administration, there were no
differences in body weight among the four groups of rats
(F{3,76} 
 
5 
 
0.24, 
 
P 
 
5 
 
0.86). Subsequently, there was a signifi-
cant decrease in body weight for the animals that received the
STZ, relative to vehicle-treated controls (F{3,76} 
 
5 
 
5.2,
 
 P 
 
,
 
0.002). This occurred during the period when all the animals
were maintained on the standard chow diets. This difference in
body weight between the STZ and vehicle-treated rats was
maintained after the change to either the HF or HC diets.
There was no significant difference in body weight between
the diabetic groups fed the two different diets (F{2,76} 
 
5 
 
0.14,
 
P 
 
, 
 
0.91), and as we expected, there was no difference in body
weight between the nondiabetics fed the different diets
(F{2,76}
 
 5 
 
0.16,
 
 P 
 
5 
 
0.86).
All plasma hormone and substrate levels were determined
on samples obtained at the conclusion of the study and the
data are presented in Table II. Whereas STZ-treated rats
had significantly lower plasma insulin levels than controls
(F{1,39} 
 
5 
 
127.0,
 
 P 
 
, 
 
0.001), there was no difference in plasma
insulin levels between the two groups of diabetic animals on
the two diets (t{26} 
 
5 2
 
0.07,
 
 P 
 
5 
 
0.41). STZ-treated rats had
higher plasma glucose levels than the nondiabetic animals
(F{1,39}
 
 5 
 
12.7,
 
 P 
 
, 
 
0.01). Plasma glucose concentrations were
significantly elevated in the diabetic group maintained on the
HC diet relative to the HF-fed diabetic group (t{26} 
 
5 2
 
3.5,
 
P 
 
, 
 
0.002). There was no statistical difference in plasma
glucose levels between the nondiabetic groups (t{9} 
 
5 
 
0.09,
 
P 
 
5 
 
0.46).
Diabetic rats exhibited lower levels of plasma leptin rela-
tive to nondiabetic rats (F{1,39} 
 
5 
 
215.9,
 
 P 
 
, 
 
0.0001) (31). In-
terestingly, plasma leptin was significantly elevated in the dia-
betic rats on the HF diet, in comparison to the diabetic rats on
the HC diet (t{27} 
 
5 
 
3.7,
 
 P 
 
, 
 
0.001). Diabetic animals had sig-
nificantly elevated triglyceride levels relative to nondiabetics
(F{1,38} 
 
5 
 
8.9,
 
 P 
 
, 
 
0.008). Individual comparisons revealed a
significant increase in plasma triglyceride concentrations be-
tween the two diabetic groups, with the HF group having
higher concentrations (t{24} 
 
5 
 
2.5,
 
 P 
 
, 
 
0.02). Rats maintained
on the HF diet had elevated plasma FFA levels compared with
those fed the HC diet (F{3,38} 
 
5 
 
15.3,
 
 P 
 
, 
 
0.004). There was
Figure 1. Mean (6SE) food in-
take for each of the four groups 
of rats averaged over the last 3 d 
of each experimental time pe-
riod.
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also a significant difference in FFA between the diabetic
groups, with the HF group having higher levels (t{23}
 
 5 
 
3.54,
 
P 
 
, 
 
0.01), whereas the difference in FFA concentrations be-
tween the nondiabetic animals was not significant (t{12} 
 
5 
 
2.2,
 
P 
 
, 
 
0.08). Plasma ketone body levels were significantly higher
in the diabetic animals fed the HF diet than those of the other
three groups (F{1,32} 
 
5 
 
7.7,
 
 P 
 
, 
 
0.009, for interaction).
Between the diabetic groups, NPY gene expression was
significantly reduced in the HF-fed animals (t{22}
 
 5 2
 
2.8,
 
 P 
 
,
 
0.009). In these same two groups, CRH gene expression was
elevated in the HF-fed group (t{16} 
 
5 
 
3.04,
 
 P 
 
, 
 
0.007) (Fig. 3).
Consistent with the food intake and body weight data, there
was no difference in either NPY (t{11}
 
 5 
 
0.087,
 
 P 
 
, 
 
0.93) or
CRH gene expression (t{8} 
 
5 2
 
1.18,
 
 P 
 
, 
 
0.27) between the
two groups of nondiabetic animals (Fig. 4).
 
Discussion
 
Consistent with previous reports, diabetic animals maintained
on a HC diet were hyperphagic relative to diabetic rats main-
tained on a HF diet, consuming 40% more calories on a daily
basis (9, 29, 30). A new finding is that the diabetic group on the
HF diet displayed significantly reduced ARC NPY expression
(
 
2
 
27%) and elevated PVN CRH expression (
 
1
 
37%) relative
to their diabetic counterparts on the HC diets. Since diabetes
results in an elevation in hypothalamic NPY mRNA concen-
trations, and a reduction in CRH mRNA concentrations in
HC-fed rats, the main effect of feeding the HF diet was there-
fore to attenuate the typical hypothalamic response to diabetes
(7). In contrast, there was no difference in caloric intake, hypo-
thalamic NPY expression, or CRH expression in nondiabetic
rats fed the different diets. In a previous experiment, Giraudo
et al. reported that nondiabetic rats fed a HF diet exhibited de-
creased NPY mRNA in the ARC (30). In that experiment,
however, the HF diet was associated with increased caloric in-
take and weight gain, an effect not observed in our study.
Since expansion of the adipose depot leads to increased secre-
tion of hormones that inhibit hypothalamic NPY gene expres-
sion (e.g., leptin and insulin), differences in weight gain associ-
ated with different HF diets may explain the earlier results.
While the experimental design did not permit direct compari-
sons of the level of neuropeptide mRNA between nondiabetic
and diabetic groups, we conclude that differences in caloric in-
take resulting from feeding diabetic rats either a HF or HC
diet are associated with changes of NPY and CRH mRNA
concentrations. Therefore, these alterations in peptide expres-
sion may have contributed to the changes in feeding behavior.
In the nondiabetic groups, there was no effect of diet on food
intake, body weight, or hypothalamic peptide expression.
It is important to note that previous reports have shown a
Figure 2. Mean (6SE) body 
weight for each of the four 
groups averaged over the last 3 d 
of each experimental time pe-
riod.
Table II. Plasma Hormone and Metabolic Substrate Concentrations
Plasma measures
Diabetic rats Nondiabetic rats
HF diet HC diet HF diet HC diet
Insulin mU/ml 18.862.6* (13) 19.163.3* (13) 116.7648.0‡ (7) 139.6615.8‡ (7)
Glucose mg/dl 398.6623.5* (13) 505.7630.4‡ (13) 139.867.0§ (6) 138.565.1§ (6)
Corticosterone mg/dl 4.761.7* (13) 4.361.8* (13) — —
Leptin ng/ml 1.160.09* (13) 0.760.03‡ (12) 4.260.29§ (7) 3.261.3§
Triglycerides mmol 4.260.63* (14) 2.561.41‡ (13) 3.461.8*‡ (7) 2.460.29‡ (7)
FFA mmol 1.060.16* (14) 0.6360.20‡ (13) 0.6760.28‡ (6) 0.4960.047‡ (7)
Ketone bodies mmol 4.860.61* (12) 1.660.41‡ (13) 0.4760.23§ (6) 0.1560.05§ (7)
All values are the mean6SE for the number of samples indicated in parentheses. Within a row, different symbols indicate significant differences of at
least P , 0.05. The numbers in the parentheses are the sample size for that specific measure and group.
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67–200% elevation in ARC NPY mRNA concentrations in di-
abetic rats compared with nondiabetic rats maintained on stan-
dard laboratory chow diets (5, 7). Thus, the modest decline in
NPY mRNA concentrations observed in the HF-fed diabetic
rats was unlikely to have normalized the increase in NPY gene
expression that occurs in diabetes. Extrapolating from a previ-
ous report in which PVN CRH mRNA levels were reduced by
44% in diabetic relative to nondiabetic rats (7), CRH gene ex-
pression in our experiment may have been nearly normalized
in the HF-fed diabetic group, relative to nondiabetic controls.
Nonetheless, factors additional to NPY and CRH likely con-
tributed to the effects of diet composition on food intake in di-
abetic rats and further studies are warranted to identify and
characterize them.
There was no difference in plasma insulin or corticosterone
levels, or body weight, between the two groups of diabetic ani-
mals. Thus, even though these two hormones are important in
the control of NPY and CRH expression in the hypothalamus,
it is unlikely that they alone can account for the differences ob-
served in food intake or neuropeptide mRNA levels. These re-
sults further suggest that factors associated with the provision
of fat fuels can also modulate hypothalamic peptide expres-
sion. However, before we can exclude the differences in corti-
costerone as contributing to the differences in peptide expres-
sion, studies examining the effect of diabetes and diet on
circadian patterning of the hypothalamic-pituitary-adrenal axis
are required. Nonetheless, our data and others (7, 32) raise the
possibility of a dissociation between levels of plasma cortico-
sterone and of PVN CRH gene expression. Specifically, the
preservation of elevated corticosterone levels despite reduced
CRH mRNA levels in the HC group of diabetic rats suggests
the possibility that corticosterone elevation occurred via fac-
tors in addition to, or separate from, CRH.
The results of this experiment are consistent with the hy-
pothesis that it is not the diet composition or hormone levels
per se that altered hypothalamic peptide expression and feed-
ing behavior, but rather is the differential ability of the dia-
betic rats to utilize fat and carbohydrate substrates (9, 11).
Thus, fuel oxidation may be an independent signal that can af-
fect hypothalamic NPY and CRH expression in a direction
consistent with feeding behavior. This interpretation of our
data suggests a possible hypothalamic mechanism by which
fuel oxidation per se may alter caloric intake. However, the
signal(s) by which the CNS might sense differences in the oxi-
dation of fuels remains unclear. One possibility is that an oxi-
dative signal is transmitted to the CNS via a neural circuit.
There is evidence that hepatic sensors can detect various nutri-
ents, metabolites, and the production of energy from oxidative
processes, and that some of these signals are transmitted to the
brain by visceral afferents to alter feeding behavior (33). If our
results are based, at least in part, on a peripheral oxidative sig-
nal which is transmitted to the CNS by visceral afferents, then
Figure 3. Mean (6SE) mRNA 
concentrations for NPY and 
CRH in the ARC and PVN for 
diabetic rats on either the HF or 
HC diets. The diabetic animals 
fed the HC diet serve as the con-
trols. Values represent area 3 
density measures derived from 
computer densitometry. The dif-
ferent letter superscripts indicate 
a significant difference of at least 
P , 0.01.
Figure 4. Mean (6SE) mRNA 
for NPY and CRH in the ARC 
and PVN for nondiabetic rats on 
either the HF or HC diet. The 
nondiabetic animals fed the
HC diet serve as the controls. 
Values represent area 3 density 
measures derived from com-
puter densitometry. The differ-
ent letter superscripts indicate a 
significant difference of at least 
P , 0.01.
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ablation of these nerves may to some extent attenuate the re-
duction in intake of HF diets, as well as peptide expression.
The recently identified hormone leptin, the product of the
ob gene expressed only in adipose tissue (34), appears to regu-
late adiposity in part by reducing food intake (35–39). In food-
deprived Long-Evans rats, leptin administration directly into
the CNS reduces food intake, body weight, and NPY expres-
sion in the hypothalamus, while increasing CRH expression
relative to vehicle-infused animals (40, 41). It is noteworthy
that these effects are essentially opposite to those observed in
uncontrolled diabetes, suggesting that leptin deficiency may
contribute to the effect of diabetes on hypothalamic function.
Moreover, STZ diabetes reduces adipocyte leptin mRNA lev-
els in mice (30), and our data are in agreement with this report
in that leptin levels were 76% lower in diabetic as compared
with nondiabetics rats. In agreement with human data, feeding
a HF diet had no effect on plasma leptin levels in the nondia-
betic control rats (27). Diabetic rats fed the HF diet had signif-
icantly elevated plasma leptin levels relative to diabetic rats
fed the HC diet (1.160.09 vs. 0.760.03 ng/ml, respectively).
However, relative to the nondiabetic controls, both groups of
diabetic rats showed an equivalent decrease in plasma leptin
levels. Since the increase in plasma leptin concentrations of
HF-fed diabetic rats was small and did not normalize the leptin
levels, the degree to which leptin contributed to the differ-
ences in feeding behavior and peptide expression is uncertain.
Differences in the circulating metabolic products generated
from fat metabolism may have altered hypothalamic peptide
expression and feeding behavior. In diabetic rats, ketone bod-
ies are elevated, and in our experiment ketone body levels
were significantly higher in the diabetic rats on the HF diet
than in any of the other groups. Moreover, ketone body up-
take is reported to be higher in the ARC and PVN relative to
other regions of the hypothalamus (29). When administered
into the CNS of rats, ketones produce a reduction in food in-
take and body weight (32). Therefore, it is possible that our re-
sults are attributable to increased CNS ketone body utiliza-
tion. On the other hand, this effect would be a complex one
because diabetic rats fed the HC diet had elevated ketone
body levels relative to nondiabetic rats, yet exhibited the
greatest changes in hypothalamic peptide expression.
It should be stressed that the reduction of food intake ex-
hibited by the diabetic rats fed the HF diet is probably not due
to an aversive consequence of the HF diet. First, when fed a
macronutrient self-selection diet, moderately diabetic rats ex-
hibit a preference for fat over carbohydrate, and the diet ulti-
mately selected by diabetic rats on such a regimen is similar to
the HF diets reported by many investigators to be effective in
reducing calorie intake (42, 43). Second, diabetic rats prefer
flavors paired with the intakes of fat (44). If fat produced aver-
sive effects, animals would be expected to avoid flavors that
were paired with those aversive effects. Third, diabetic rats av-
idly consume corn oil over repeated trials even though oil con-
sumption reduces subsequent food intake (10). Finally, condi-
tion taste aversion acquisition in diabetic rats does not occur in
response to a HF diet if the diet is not given immediately after
the onset of diabetes (45). Taken together, these data suggest
that an aversion to the HF diet is unlikely to explain the reduc-
tion of food intake in diabetic rats.
In conclusion, the effect of a HF diet in diabetic animals
was to reduce food intake to control levels, and attenuate the
diabetes-induced changes in hypothalamic NPY and CRH
mRNA expression. Moreover, the lack of effect of HF feeding
on caloric intake in nondiabetic animals was accompanied by a
lack of effect on hypothalamic neuropeptide expression. These
observations are consistent with a role for NPY and CRH in
the HF-feeding response to diabetes.
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